KEGG   PATHWAY: scam04370
Entry
scam04370                   Pathway                                
Name
VEGF signaling pathway - Struthio camelus australis (South African ostrich)
Description
There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgamma;PKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling.
Class
Environmental Information Processing; Signal transduction
Pathway map
scam04370  VEGF signaling pathway
scam04370

Other DBs
GO: 0048010
Organism
Struthio camelus australis (South African ostrich) [GN:scam]
Gene
104138549  KDR; vascular endothelial growth factor receptor 2 [KO:K05098] [EC:2.7.10.1]
104138865  MAPK1; LOW QUALITY PROTEIN: mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
104139169  PRKCB; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
104139226  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
104139401  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
104139403  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
104140194  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
104141153  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
104141709  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
104141741  SRC; proto-oncogene tyrosine-protein kinase Src [KO:K05704] [EC:2.7.10.2]
104141776  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
104141884  PIK3CD; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
104142331  MAPKAPK2; MAP kinase-activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]
104142365  NRAS; GTPase NRas [KO:K07828]
104142512  [KO:K01116] [EC:3.1.4.11]
104142612  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
104142613  PLA2G4A; cytosolic phospholipase A2 [KO:K16342] [EC:3.1.1.4]
104143574  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
104143715  HRAS; GTPase HRas [KO:K02833]
104144489  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
104145759  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
104145800  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
104146830  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
104147858  MAPKAPK3; MAP kinase-activated protein kinase 3 [KO:K04444] [EC:2.7.11.1]
104147993  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
104149338  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
104149649  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
104149888  PTK2; LOW QUALITY PROTEIN: focal adhesion kinase 1 [KO:K05725] [EC:2.7.10.2]
104149966  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
104150038  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
104150063  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
104150199  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
104150358  PPP3CC; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
104150403  [KO:K16342] [EC:3.1.1.4]
104150404  [KO:K16342] [EC:3.1.1.4]
104150405  [KO:K16342] [EC:3.1.1.4]
104150425  PLA2G4B; cytosolic phospholipase A2 beta [KO:K16342] [EC:3.1.1.4]
104150428  [KO:K16342] [EC:3.1.1.4]
104150429  [KO:K16342] [EC:3.1.1.4]
104150430  [KO:K16342] [EC:3.1.1.4]
104150431  [KO:K16342] [EC:3.1.1.4]
104150432  [KO:K16342] [EC:3.1.1.4]
104150433  [KO:K16342] [EC:3.1.1.4]
104151524  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
104151532  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
104151745  VEGFA; vascular endothelial growth factor A [KO:K05448]
104151871  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
104152220  PXN; paxillin isoform X1 [KO:K05760]
104152703  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
104152968  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
104153496  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
104153640  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
104153653  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
104154112  KRAS; GTPase KRas isoform X1 [KO:K07827]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C00533  Nitric oxide
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01312  Prostaglandin I2
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.
  Title
VEGF-receptor signal transduction.
  Journal
Trends Biochem Sci 28:488-94 (2003)
DOI:10.1016/S0968-0004(03)00193-2
Reference
  Authors
Matsumoto T, Claesson-Welsh L.
  Title
VEGF receptor signal transduction.
  Journal
Sci STKE 2001:RE21 (2001)
DOI:10.1126/stke.2001.112.re21
Reference
  Authors
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.
  Title
Vascular endothelial growth factor and angiogenesis.
  Journal
Pharmacol Rev 56:549-80 (2004)
DOI:10.1124/pr.56.4.3
Reference
  Authors
Takahashi H, Shibuya M.
  Title
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
  Journal
Clin Sci (Lond) 109:227-41 (2005)
DOI:10.1042/CS20040370
Reference
  Authors
Zachary I.
  Title
VEGF signalling: integration and multi-tasking in endothelial cell biology.
  Journal
Biochem Soc Trans 31:1171-7 (2003)
DOI:10.1042/bst0311171
Reference
  Authors
Munoz-Chapuli R, Quesada AR, Angel Medina M.
  Title
Angiogenesis and signal transduction in endothelial cells.
  Journal
Cell Mol Life Sci 61:2224-43 (2004)
DOI:10.1007/s00018-004-4070-7
Reference
  Authors
Lamalice L, Houle F, Jourdan G, Huot J.
  Title
Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
  Journal
Oncogene 23:434-45 (2004)
DOI:10.1038/sj.onc.1207034
Reference
  Authors
Shu X, Wu W, Mosteller RD, Broek D.
  Title
Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.
  Journal
Mol Cell Biol 22:7758-68 (2002)
DOI:10.1128/MCB.22.22.7758-7768.2002
Related
pathway
scam00590  Arachidonic acid metabolism
scam04010  MAPK signaling pathway
scam04020  Calcium signaling pathway
scam04510  Focal adhesion
KO pathway
ko04370   

DBGET integrated database retrieval system